This volume reviews comprehensively the present understanding of the clinical pharmacology and therapeutics of currently available antihypertensive agents. As fewer new molecules are entering development it becomes increasingly important to utilise existing drugs in a way that exploits their full potential through a greater understanding of their molecular biology and pharmacogenomics.